Growing Demand for Sugar-Based Excipients in Pharmaceutical Formulations Drives Market Growth

Sugar-based excipients have gained widespread acceptance in the pharmaceutical industry as ingredients in tablet formulations. They are commonly used to mask the bitter taste of active pharmaceutical ingredients (APIs), making the tablets more palatable for patients. With the growing preference for direct compression as a method of tablet manufacture, there has been an increased demand for compressible sugar-based excipients.

Direct compression is a popular tablet manufacturing method because it offers advantages such as cost-effectiveness, simplicity, and improved efficiency. Sugar-based excipients, such as lactose, mannitol, sorbitol, and microcrystalline cellulose, are commonly used in direct compression formulations due to their compressibility, flowability, and compatibility with a wide range of APIs. These excipients can be easily blended with APIs and other excipients, and they exhibit good compressibility, allowing for the production of tablets with consistent hardness, friability, and disintegration properties.

Sugar-based excipients also offer the benefit of being widely accepted as safe for oral consumption, as they are commonly used in food and confectionery products. They are generally considered to be biocompatible, non-toxic, and non-irritating, making them suitable for use in pharmaceutical formulations. Additionally, sugar-based excipients can provide functionality beyond taste-masking, such as improving tablet disintegration and dissolution, enhancing drug stability, and facilitating tablet coating.

Overall, the demand for compressible sugar-based excipients has increased in the pharmaceutical industry due to their versatility, ease of use in direct compression manufacturing, and ability to improve the palatability and patient acceptability of tablets.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐๐ƒ๐… ๐๐ซ๐จ๐œ๐ก๐ฎ๐ซ๐ž ๐š๐ญ: https://www.alliedmarketresearch.com/request-toc-and-sample/2819

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

  1. DFE Pharma
  2. BASF SE
  3. Ashland
  4. Archer Daniels Midland Company
  5. Meggle AG
  6. Associated British Foods
  7. Cargill
  8. FMC
  9. The Lubrizol
  10. Roquette Frรจres โ€ƒ
  11. ๐’๐ฎ๐ ๐š๐ซ-๐๐š๐ฌ๐ž๐ ๐„๐ฑ๐œ๐ข๐ฉ๐ข๐ž๐ง๐ญ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
  12. By Product:
  • Actual sugar: This includes sugar derived from natural sources, such as sucrose, lactose, and maltose, which are commonly used in pharmaceutical formulations.
  • Sugar alcohols: This category includes sugar alcohols like mannitol, sorbitol, and xylitol, which are widely used as excipients in pharmaceuticals due to their sweetness, low caloric content, and ability to improve tablet characteristics.
  • Artificial sweeteners: These are synthetic sweeteners like aspartame, saccharin, and cyclamate, which are used as sugar substitutes in pharmaceutical formulations to achieve desired taste profiles.
  1. By Type:
  • Powders/Granules: Sugar-based excipients in powder or granule form are commonly used in direct compression and wet granulation methods of tablet manufacturing.
  • Direct compression sugars: These are specifically processed sugars that are used for direct compression tablet formulations, as they possess good flowability and compressibility properties.
  • Crystals: Sugar crystals are used as excipients in various pharmaceutical formulations, especially in liquid dosage forms.
  • Syrups: Sugar-based syrups, such as simple syrup or flavored syrup, are used as excipients in liquid formulations to provide sweetness, flavor, and preservation.
  1. By Application:
  • Fillers and Diluents: Sugar-based excipients are commonly used as fillers and diluents in tablet formulations to provide bulk, aid in compression, and improve tablet properties.
  • Flavoring agents: Sugar-based excipients are used as flavoring agents to mask the bitter taste of APIs and improve the palatability of tablets.
  • Tonicity agents: Sugar-based excipients can be used as tonicity agents to adjust the osmotic pressure of liquid dosage forms, such as eye drops or injections.
  1. By Region:
  • North America: This includes the United States, Canada, and Mexico, where there is a significant demand for sugar-based excipients in the pharmaceutical industry.
  • Europe: This includes France, Germany, Italy, Spain, the United Kingdom, and the rest of Europe, where sugar-based excipients are widely used in pharmaceutical formulations.
  • Asia-Pacific: This includes China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific, where there is a growing demand for sugar-based excipients due to increasing pharmaceutical manufacturing activities.
  • LAMEA: This includes Brazil, South Africa, Saudi Arabia, and the rest of Latin America, Middle East, and Africa, where there is a potential for growth in the sugar-based excipients market.

๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž: https://www.alliedmarketresearch.com/purchase-enquiry/2819

๐…๐‘๐„๐๐”๐„๐๐“๐‹๐˜ ๐€๐’๐Š๐„๐ƒ ๐๐”๐„๐’๐“๐ˆ๐Ž๐๐’?

  1. What are the key drivers for the growth of the sugar-based excipients market in the pharmaceutical industry?
  2. How are sugar alcohols used as excipients in pharmaceutical formulations, and what benefits do they offer?
  3. What are the different types of sugar-based excipients used in tablet manufacturing, and how do they differ in terms of their properties and applications?
  4. What are the main applications of sugar-based excipients in pharmaceutical formulations, apart from taste-masking?
  5. How does the demand for sugar-based excipients vary across different regions, such as North America, Europe, Asia-Pacific, and LAMEA?
  6. What are the regulatory requirements and guidelines for the use of sugar-based excipients in pharmaceutical formulations?
  7. What are the challenges and limitations associated with the use of sugar-based excipients in tablet manufacturing?
  8. How are advancements in sugar processing technologies impacting the development of sugar-based excipients for pharmaceutical applications?
  9. What are the emerging trends and innovations in the sugar-based excipients market, such as novel sugar-based excipients with improved functionalities?
  10. How do sugar-based excipients compare to other types of excipients in terms of their advantages, limitations, and market share in the pharmaceutical industry?

๐๐ฎ๐ฒ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐’๐ฎ๐ ๐š๐ซ-๐๐š๐ฌ๐ž๐ ๐„๐ฑ๐œ๐ข๐ฉ๐ข๐ž๐ง๐ญ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐š๐ญ: https://www.alliedmarketresearch.com/sugar-based-excipients-market/purchase-options

Leave a comment

Your email address will not be published. Required fields are marked *